J.W. Coons Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.8M | Buy |
9,691
+24
| +0.2% | +$4.46K | 0.41% | 64 |
|
2025
Q1 | $2.03M | Sell |
9,667
-247
| -2% | -$51.8K | 0.53% | 52 |
|
2024
Q4 | $1.76M | Sell |
9,914
-315
| -3% | -$56K | 0.45% | 57 |
|
2024
Q3 | $2.02M | Sell |
10,229
-75
| -0.7% | -$14.8K | 0.5% | 52 |
|
2024
Q2 | $1.77M | Sell |
10,304
-5
| -0% | -$858 | 0.43% | 56 |
|
2024
Q1 | $1.88M | Sell |
10,309
-37
| -0.4% | -$6.74K | 0.42% | 52 |
|
2023
Q4 | $1.6M | Sell |
10,346
-154
| -1% | -$23.9K | 0.43% | 56 |
|
2023
Q3 | $1.57M | Sell |
10,500
-780
| -7% | -$116K | 0.45% | 53 |
|
2023
Q2 | $1.52M | Sell |
11,280
-720
| -6% | -$97K | 0.42% | 56 |
|
2023
Q1 | $1.91M | Sell |
12,000
-2,890
| -19% | -$461K | 0.55% | 48 |
|
2022
Q4 | $2.41M | Sell |
14,890
-1,600
| -10% | -$259K | 0.72% | 41 |
|
2022
Q3 | $2.21M | Buy |
16,490
+569
| +4% | +$76.4K | 0.84% | 36 |
|
2022
Q2 | $2.43M | Sell |
15,921
-154
| -1% | -$23.5K | 0.86% | 32 |
|
2022
Q1 | $2.6M | Buy |
16,075
+151
| +0.9% | +$24.4K | 0.77% | 38 |
|
2021
Q4 | $2.16M | Sell |
15,924
-2,297
| -13% | -$311K | 0.65% | 43 |
|
2021
Q3 | $1.97M | Buy |
18,221
+146
| +0.8% | +$15.8K | 0.67% | 43 |
|
2021
Q2 | $2.03M | Sell |
18,075
-412
| -2% | -$46.3K | 0.72% | 42 |
|
2021
Q1 | $2M | Buy |
18,487
+957
| +5% | +$104K | 0.72% | 40 |
|
2020
Q4 | $1.88M | Buy |
17,530
+5,214
| +42% | +$559K | 0.72% | 41 |
|
2020
Q3 | $1.08M | Buy |
12,316
+1,641
| +15% | +$144K | 0.45% | 60 |
|
2020
Q2 | $1.05M | Buy |
10,675
+1,106
| +12% | +$109K | 0.47% | 64 |
|
2020
Q1 | $730K | Buy |
+9,569
| New | +$730K | 0.38% | 74 |
|